|
@EBDgroup | |||||
|
Speaking at #BiotechShowcase 2020, @jmaxlevin, of @OvidRx gives an update the company's progress with its investigational medicine, OV101 (gaboxadol) for the treatment of Angelman syndrome and Fragile X syndrome >> youtu.be/gRo_pOWcaec @cglifeagency @demycolton
|
||||||
|
||||||